Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Imaging

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Study title: Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging : Frühwald MC, Rickert CH, O'Dorisio MS, Madsen M, Warmuth-Metz M, Khanna G, Paulus W, Kühl J, Jürgens H, Schneider P, Müller HL; Clin Cancer Res. 2004 May 1;10(9):2997-3006
    Active substance: (111In) INDIUM CHLORIDE/PENTETREOTIDE
    Study summary document link (including results):
    View full study record
    Document reference: 21232
    Study title: Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL.. Epub 2005 Jun 18. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. [yen-2005-a]Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1152-9. Yen RF 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48716
    Study title: Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T. and al; Pediatrics International. 42(3):285-8, 2000 Jun.Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T. and al; Pediatrics International. 42(3):285-8, 2000 Jun.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22150
    Study title: [Diagnostic imaging of piriform sinus fistulas]. [Spanish] Molina Fabrega R. And al; Radiologia. 48(6):385-90, 2006 Nov-Dec.[Diagnostic imaging of piriform sinus fistulas]. [Spanish] Molina Fabrega R. And al; Radiologia. 48(6):385-90, 2006 Nov-Dec.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22140
    Study title: Diffuse cavernous hemangioma of the rectosigmoid colon: imaging findings. Djouhri H. And al; Journal of Computer Assisted Tomography. 22(6):851-5, 1998 Nov-Dec.Diffuse cavernous hemangioma of the rectosigmoid colon: imaging findings. Djouhri H. And al; Journal of Computer Assisted Tomography. 22(6):851-5, 1998 Nov-Dec.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22171
    Study title: angiography with metrizamide in neuroradiological examinations; VALK J Diagn. Imaging; 1979 vol.48 p.199-204angiography with metrizamide in neuroradiological examinations; VALK J Diagn. Imaging; 1979 vol.48 p.199-204
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22147
    Study title: Imaging findings in acute neck infection due to pyriform sinus fistula.Gan YU. Lam SL.; Annals of the Academy of Medicine, Singapore. 33(5):636-40, 2004 Sep.Imaging findings in acute neck infection due to pyriform sinus fistula.Gan YU. Lam SL.; Annals of the Academy of Medicine, Singapore. 33(5):636-40, 2004 Sep.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22185
    Study title: Multi-modality evaluation of the abnormalities of the aortic arches in children: techniques and imaging spectrum with emphasis on MRI. [Review] [21 refs] Oddone M. and al; Pediatric Radiology. 35(10):947-60, 2005 Oct. Multi-modality evaluation of the abnormalities of the aortic arches in children: techniques and imaging spectrum with emphasis on MRI. [Review] [21 refs] Oddone M. and al; Pediatric Radiology. 35(10):947-60, 2005 Oct.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22134
    Study title: Neck infection associated with pyriform sinus fistula: imaging findings.; Park SW. And al; Ajnr: American Journal of Neuroradiology. 21(5):817-22, 2000 May.Neck infection associated with pyriform sinus fistula: imaging findings.; Park SW. And al; Ajnr: American Journal of Neuroradiology. 21(5):817-22, 2000 May.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22195
    Study title: Angiography with metrizamide in neuroradiological examinations; VALK J Diagn. Imaging; 1979 vol.48 p.199-204Angiography with metrizamide in neuroradiological examinations; VALK J Diagn. Imaging; 1979 vol.48 p.199-204
    Active substance: BISACODYL
    Study summary document link (including results):
    View full study record
    Document reference: 22716
    Study title: Maini et al. Pediatric duodenal perforation demonstrated by hepatobiliary imagingClin Nucl Med. 2000 Jan; 25(1):41-3
    Active substance: BRIDATEC
    Study summary document link (including results): 2011-09 GE Bridatec response List of published articles.doc
    View full study record
    Document reference: 48191
    Study title: Apostolopoulou, S.C., et al., Doppler tissue imaging evaluation of right ventricular function at rest and during dobutamine infusion in patients after repair of tetralogy of Fallot. Int J Cardiovasc Imaging, 2007. 23(1): p. 25-31. 2.Apostolopoulou, S.C., et al., Doppler tissue imaging evaluation of right ventricular function at rest and during dobutamine infusion in patients after repair of tetralogy of Fallot. Int J Cardiovasc Imaging, 2007. 23(1): p. 25-31. 2.
    Active substance: DOBUTAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 26285
    Study title: Ann Oncol. 2002 Jan;13(1):157-60. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, Schober O.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28161
    Study title: An open, non-comparative, pilot study using magnetic resonance imaging (MRI) scans to investigate any arthropathic effects of a 14 day course of ciprofloxacin bd oral tablets on the joints of children with Pseudomonas aeruginosa exacerbations of cystic fibrosis.
    Active substance: CIPROFLOXACIN
    Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf
    View full study record
    Document reference: 24208
    Study title: AN OPEN, NON-COMPARATIVE, PILOT STUDY USING MAGNETIC RESONANCE IMAGING (MRI) SCANS TO INVESTIGATE ANY ARTHROPATIC EFFECTS OF A 14 DAY COURSE OF CIPROFLOXACIN BD ORAL TABLETS ON THE JOINTS OF CHILDREN WITH PSEUDOMONAS AERUGINOSA EXACERBATION OF CYSTIC FIBROSIS.
    Active substance: CIPROFLOXACIN
    Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf
    View full study record
    Document reference: 24216
    Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili K, Hall M, Piepsz A, Wissing KM, Collier F, Schulman C, Avni FE.
    Active substance: CHROMIUM 51
    Study summary document link (including results): Ismaili K et al 2006.pdf
    View full study record
    Document reference: 24087
    Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.
    Active substance: TRIMETHOPRIM
    Study summary document link (including results):
    View full study record
    Document reference: 46774
    Study title: Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278
    Active substance: IOVERSOL
    Study summary document link (including results):
    View full study record
    Document reference: 30435
    Study title: Ment Retard Dev Disabil Res Rev. 2000;6(3):220-6. Structural and functional imaging in children with partial epilepsy. Gaillard WD.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28174
    Study title: Neuroimaging Clin N Am. 2003 Nov;13(4):705-16, viii. Imaging the epileptic brain with positron emission tomography. Juhász C, Chugani HT.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28130
    1  2  3  4  5  6  7  8  9  Next» Last»»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 23 09:48:50 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA